ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Neurology

Top Neurology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Narcotics Antipsychotics to Patients Over 65 Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YANCHUN ZHANG MD

Neurology

12,891

$1.88M

346
140 are 65+

16%
patients 65+ receiving antipsychotics

Avg: 2%

42%
prescriptions for brand name drugs

Avg: 34%

DHARAMSI SHAH M.D.

Neurology

7,618

$1.37M

346
53 are 65+

79%
patients 65+ receiving antipsychotics

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 34%

ALLEN RUBIN MD

Neurology

6,038

$921K

223
62 are 65+

21%
patients 65+ receiving antipsychotics

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 34%

YAN LUPYAN MD

Neurology

5,764

$849K

672
617 are 65+

2%
patients 65+ receiving antipsychotics

Avg: 2%

43%
prescriptions for brand name drugs

Avg: 34%

ERIC GELLER M.D.

Neurology

5,562

$909K

253
55 are 65+

N/A

32%
prescriptions for brand name drugs

Avg: 34%

NAGESH KRISH M.D., P.A.

Neurology

4,257

$739K

408
255 are 65+

9%
patients 65+ receiving antipsychotics

Avg: 2%

51%
prescriptions for brand name drugs

Avg: 34%

THOMAS MIRSEN MD

Neurology

4,009

$914K

392
220 are 65+

6%
patients 65+ receiving antipsychotics

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 34%

ELIOT CHODOSH M.D.

Neurology

3,835

$620K

351
282 are 65+

N/A

27%
prescriptions for brand name drugs

Avg: 34%

NALINI PRASAD

Neurology

3,814

$574K

465
378 are 65+

4%
patients 65+ receiving antipsychotics

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 34%

ROGER BEHAR M.D.

Neurology

3,689

$928K

394
329 are 65+

N/A

36%
prescriptions for brand name drugs

Avg: 34%

LORETO LIZARDO M.D.

Neurology

3,617

$616K

167
45 are 65+

71%
patients 65+ receiving antipsychotics

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 34%

SYED JAFRI MD

Neurology

3,465

$489K

437
316 are 65+

N/A

33%
prescriptions for brand name drugs

Avg: 34%

GREGORY ANSELMI M.D.

Neurology

3,165

$540K

294
210 are 65+

6%
patients 65+ receiving antipsychotics

Avg: 2%

40%
prescriptions for brand name drugs

Avg: 34%

MOHSIN ALI M.D.

Neurology

3,086

$220K

223
37 are 65+

N/A

7%
prescriptions for brand name drugs

Avg: 34%

MARY ANN PICONE MD

Neurology

3,072

$3.52M

206
48 are 65+

N/A

38%
prescriptions for brand name drugs

Avg: 34%

STEVEN BROMLEY MD

Neurology

2,951

$1.02M

323
177 are 65+

N/A

41%
prescriptions for brand name drugs

Avg: 34%

MATTHEW DELUCA MD

Neurology

2,841

$620K

293
212 are 65+

9%
patients 65+ receiving antipsychotics

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 34%

JOSEPH HERBERT M.D.

Neurology

2,837

$3.65M

198
44 are 65+

N/A

47%
prescriptions for brand name drugs

Avg: 34%

ANTWAN AHAD MD

Neurology

2,781

$487K

261
188 are 65+

N/A

47%
prescriptions for brand name drugs

Avg: 34%

AMOS KATZ MD

Neurology

2,630

$2.14M

253
135 are 65+

N/A

44%
prescriptions for brand name drugs

Avg: 34%

STEVE LEQUERICA MD

Neurology

2,612

$842K

262
181 are 65+

N/A

40%
prescriptions for brand name drugs

Avg: 34%

FAROOQ REHMAN M.D.

Neurology

2,585

$479K

299
220 are 65+

8%
patients 65+ receiving antipsychotics

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 34%

KEVIN HUNTER MD

Neurology

2,536

$871K

326
250 are 65+

N/A

28%
prescriptions for brand name drugs

Avg: 34%

GERRARD FERRER D.O.

Neurology

2,528

$572K

210
142 are 65+

N/A

36%
prescriptions for brand name drugs

Avg: 34%

MAUREEN GOTTFRIED DO

Neurology

2,527

$563K

338
253 are 65+

7%
patients 65+ receiving antipsychotics

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 34%

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank